DossierENTITY

triple-hormone drug

Coverage of triple-hormone drug in the Nexus archive.

Earliest in view: Jul 23 · 11:10 UTCMost recent: Jul 23 · 11:10 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 23 · 11:10 UTCQUARTZ
Eli Lilly is pushing its next-generation weight loss drug approval filing to early 2027
Eli Lilly is delaying the FDA approval filing for its next-generation triple-hormone weight loss drug from this year to early 2027. The company had previously indicated it could seek approval as early as 2024.